Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Gastro-resistant and prolonged-release oral capsule (dose form) | Is a | kapsel med förlängd frisättning | false | Inferred relationship | Some | ||
| Gastro-resistant and prolonged-release oral capsule (dose form) | Is a | Prolonged-release oral capsule | true | Inferred relationship | Some | ||
| Gastro-resistant and prolonged-release oral capsule (dose form) | Has dose form administration method (attribute) | Swallow (administration method) | true | Inferred relationship | Some | ||
| Gastro-resistant and prolonged-release oral capsule (dose form) | Has dose form intended site (attribute) | Oral | true | Inferred relationship | Some | ||
| Gastro-resistant and prolonged-release oral capsule (dose form) | Has basic dose form (attribute) | Capsule | true | Inferred relationship | Some | ||
| Gastro-resistant and prolonged-release oral capsule (dose form) | Is a | Gastro-resistant oral capsule (dose form) | true | Inferred relationship | Some | ||
| Gastro-resistant and prolonged-release oral capsule (dose form) | Has dose form transformation (attribute) | No transformation | true | Inferred relationship | Some | ||
| Gastro-resistant and prolonged-release oral capsule (dose form) | Has dose form release characteristic (attribute) | Delayed-release and prolonged-release (release characteristic) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely diclofenac sodium 75 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has manufactured dose form | True | Gastro-resistant and prolonged-release oral capsule (dose form) | Inferred relationship | Some | |
| minocyklin 100 mg, enterodragerad depåkapsel | Has manufactured dose form | False | Gastro-resistant and prolonged-release oral capsule (dose form) | Inferred relationship | Some | |
| Dexrabeprazole sodium 10 mg and domperidone 30 mg gastro-resistant and prolonged-release oral capsule | Has manufactured dose form | True | Gastro-resistant and prolonged-release oral capsule (dose form) | Inferred relationship | Some | |
| Domperidone 30 mg and omeprazole 20 mg gastro-resistant and prolonged-release oral capsule | Has manufactured dose form | True | Gastro-resistant and prolonged-release oral capsule (dose form) | Inferred relationship | Some |
This concept is not in any reference sets